These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

40 related articles for article (PubMed ID: 19517465)

  • 1. Receptor binding activities of Chlorella on cysteinyl leukotriene CysLT, glutamate AMPA, ion channels, purinergic P 2Y, tachykinin NK2 receptors and adenosine transporter.
    Cheng FC; Feng JJ; Chen KH; Imanishi H; Fujishima M; Takekoshi H; Naoki Y; Shimoda M
    Phytother Res; 2010 Jan; 24(1):43-8. PubMed ID: 19517465
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MEN15596, a novel nonpeptide tachykinin NK2 receptor antagonist.
    Cialdai C; Tramontana M; Patacchini R; Lecci A; Catalani C; Catalioto RM; Meini S; Valenti C; Altamura M; Giuliani S; Maggi CA
    Eur J Pharmacol; 2006 Nov; 549(1-3):140-8. PubMed ID: 16979621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MEN 11420 (Nepadutant), a novel glycosylated bicyclic peptide tachykinin NK2 receptor antagonist.
    Catalioto RM; Criscuoli M; Cucchi P; Giachetti A; Gianotti D; Giuliani S; Lecci A; Lippi A; Patacchini R; Quartara L; Renzetti AR; Tramontana M; Arcamone F; Maggi CA
    Br J Pharmacol; 1998 Jan; 123(1):81-91. PubMed ID: 9484857
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological characterization of the first potent and selective antagonist at the cysteinyl leukotriene 2 (CysLT(2)) receptor.
    Wunder F; Tinel H; Kast R; Geerts A; Becker EM; Kolkhof P; Hütter J; Ergüden J; Härter M
    Br J Pharmacol; 2010 May; 160(2):399-409. PubMed ID: 20423349
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional characterisation of receptors for cysteinyl leukotrienes in smooth muscle.
    Jonsson EW
    Acta Physiol Scand Suppl; 1998 Mar; 641():1-55. PubMed ID: 9597121
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel compounds that interact with both leukotriene B4 receptors and vanilloid TRPV1 receptors.
    McHugh D; McMaster RS; Pertwee RG; Roy S; Mahadevan A; Razdan RK; Ross RA
    J Pharmacol Exp Ther; 2006 Feb; 316(2):955-65. PubMed ID: 16207832
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro and in vivo pharmacological characterization of PF-01354082, a novel partial agonist selective for the 5-HT(4) receptor.
    Mikami T; Komada T; Sugimoto H; Suzuki K; Ohmi T; Kimura N; Naganeo R; Nakata E; Nakatani K; Toga T; Eda H; Sakakibara M
    Eur J Pharmacol; 2009 May; 609(1-3):5-12. PubMed ID: 19285067
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SSR240600 [(R)-2-(1-[2-[4-[2-[3,5-bis(trifluoromethyl)phenyl]acetyl]-2-(3,4-dichlorophenyl)-2-morpholinyl]ethyl]- 4-piperidinyl)-2-methylpropanamide], a centrally active nonpeptide antagonist of the tachykinin neurokinin-1 receptor: I. biochemical and pharmacological characterization.
    Emonds-Alt X; Proietto V; Steinberg R; Oury-Donat F; Vigé X; Vilain P; Naline E; Daoui S; Advenier C; Le Fur G; Maffrand JP; Soubrié P; Pascal M
    J Pharmacol Exp Ther; 2002 Dec; 303(3):1171-9. PubMed ID: 12438541
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of glutamate receptors promotes a calcium-dependent and transporter-mediated release of purines in cultured avian retinal cells: possible involvement of calcium/calmodulin-dependent protein kinase II.
    Paes-de-Carvalho R; Dias BV; Martins RA; Pereira MR; Portugal CC; Lanfredi C
    Neurochem Int; 2005 May; 46(6):441-51. PubMed ID: 15769546
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The molecular characterization and tissue distribution of the human cysteinyl leukotriene CysLT(2) receptor.
    Takasaki J; Kamohara M; Matsumoto M; Saito T; Sugimoto T; Ohishi T; Ishii H; Ota T; Nishikawa T; Kawai Y; Masuho Y; Isogai T; Suzuki Y; Sugano S; Furuichi K
    Biochem Biophys Res Commun; 2000 Aug; 274(2):316-22. PubMed ID: 10913337
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction of the novel antipsychotic drug amperozide and its metabolite FG5620 with central nervous system receptors and monoamine uptake sites: relation to behavioral and clinical effects.
    Svartengren J; Pettersson E; Björk A
    Biol Psychiatry; 1997 Aug; 42(4):247-59. PubMed ID: 9270901
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The new 2,3-benzodiazepine derivative EGIS-8332 inhibits AMPA/kainate ion channels and cell death.
    Vegh MG; Kovács AD; Kovács G; Szabó G; Tihanyi K; Hársing LG; Lévay G
    Neurochem Int; 2007 Feb; 50(3):555-63. PubMed ID: 17147974
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Affinity of cyamemazine metabolites for serotonin, histamine and dopamine receptor subtypes.
    Benyamina A; Arbus C; Nuss P; Garay RP; Neliat G; Hameg A
    Eur J Pharmacol; 2008 Jan; 578(2-3):142-7. PubMed ID: 17936750
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of adenosine and some of its structural analogues on the conductance of NMDA receptor channels in a subset of rat neostriatal neurones.
    Nörenberg W; Wirkner K; Illes P
    Br J Pharmacol; 1997 Sep; 122(1):71-80. PubMed ID: 9298530
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of the cysteinyl leukotriene receptors cysLT(1) and cysLT(2) in aspirin-sensitive and aspirin-tolerant chronic rhinosinusitis.
    Corrigan C; Mallett K; Ying S; Roberts D; Parikh A; Scadding G; Lee T
    J Allergy Clin Immunol; 2005 Feb; 115(2):316-22. PubMed ID: 15696087
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pentylenetetrazole-induced seizures affect binding site densities for GABA, glutamate and adenosine receptors in the rat brain.
    Cremer CM; Palomero-Gallagher N; Bidmon HJ; Schleicher A; Speckmann EJ; Zilles K
    Neuroscience; 2009 Sep; 163(1):490-9. PubMed ID: 19345722
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Leukotrienes: potential therapeutic targets in cardiovascular diseases].
    Bäck M
    Bull Acad Natl Med; 2006 Oct; 190(7):1511-8; discussion 1518-21. PubMed ID: 17450683
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studies of receptors and modulatory mechanisms in functional responses to cysteinyl-leukotrienes in smooth muscle.
    Bäck M
    Acta Physiol Scand Suppl; 2002 Feb; 648():1-55. PubMed ID: 11913222
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Competitive antagonism of glutamate receptor channels by substituted benzazepines in cultured cortical neurons.
    Swartz KJ; Koroshetz WJ; Rees AH; Huettner JE
    Mol Pharmacol; 1992 Jun; 41(6):1130-41. PubMed ID: 1352036
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biexponential kinetics of [3H]MK-801 binding: evidence for access to closed and open N-methyl-D-aspartate receptor channels.
    Javitt DC; Zukin SR
    Mol Pharmacol; 1989 Apr; 35(4):387-93. PubMed ID: 2468076
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 2.